Anodyne Nanotech
Developing transdermal therapeutics for chronic care.
Biotechnology
📍 Boston, MA
Current Valuation
Private
PRIVATE
Developing transdermal therapeutics for chronic care. Headquartered in Boston, MA. Raised $12.6M in Series A funding in June 2026 led by Velocity Partners VC.
Company Profile
Last Round
Series A — $13M (Jun 2026) · Lead: Velocity Partners VC
Fundraising Status
Series A · $13M · this month
privateTotal raised $13M1 disclosed rounds
Funding History
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Series A | $13M | Jun 2026 | Velocity Partners VC | — |
Investors
Velocity Partners VC · Evercurious VC · Relativity Healthcare Partners
BiotechnologyClinical-stage BiotechRecently Funded
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.